In prostate cancer cells, insulin-like growth factor-1 (IGF-1)-mediated mTOR pathway activation positively modulated survivin levels by increasing the translation of a survivin mRNA pool [51]. The gene discussed is IGF1; the disease is prostate carcinoma.